Crinetics Pharmaceuticals Inc buy SVB Leerink LLC
Start price
29.09.25
/
50%
€38.40
Target price
29.09.26
€75.07
Performance (%)
-14.58%
Price
17.03.26
€32.80
Summary
This prediction is currently active. The prediction for Crinetics Pharmaceuticals Inc disappoints with a performance of -14.58%. This prediction currently runs until 29.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 3.145% | 3.145% |
| iShares Core DAX® | -2,12 % | -7,97 % |
| iShares Nasdaq 100 | -1,32 % | -0,07 % |
| iShares Nikkei 225® | -0,32 % | -6,38 % |
| iShares S&P 500 | -1,57 % | -1,97 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Leerink Partners from $80.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat